Literature DB >> 11406908

DICE 2: a further investigation of the effects of chance in life, death and subgroup analyses.

M Clarke1, J Halsey.   

Abstract

In an investigation into how chance might influence the distribution of deaths in a randomised trial and the time of those deaths, and to highlight the possible dangers of subgroup analyses, 100 randomised controlled trials were simulated and 50 subgroup pairs were simulated for some of these trials. Each of 580 control patients from a colorectal cancer trial was randomly coded to simulate allocation to treatment or control, the main outcome measure being time to death. Not surprisingly, most of the 100 trials gave non-significant results. Four were conventionally significant with logrank 2p-values of less than 0.05. The most extreme result was associated with a logrank 2p-value of 0.003, showing an absolute reduction in four-year mortality of 40% (SD 15) for patients allocated to treatment. One of the simulated prognostic factors for this trial (subgroup 13) showed that mortality for one type of patient was non-significantly slightly increased by treatment, whereas treatment reduced four-year mortality by 64% (SD 16) among the other patients in the trial (2p = 0.00006). Similar, extreme results were found for a trial of borderline statistical significance overall. Chance can influence the overall results of any randomised controlled trial, regardless of how well it is conducted, and can play an even more powerful role in the results of subgroup analyses. This should be borne in mind both by trialists when reporting their results and by readers and reviewers of those reports.

Entities:  

Mesh:

Year:  2001        PMID: 11406908

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  8 in total

1.  How to spot bias and other potential problems in randomised controlled trials.

Authors:  S C Lewis; C P Warlow
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-02       Impact factor: 10.154

2.  Patient-level pooled analysis of adjudicated gastrointestinal outcomes in celecoxib clinical trials: meta-analysis of 51,000 patients enrolled in 52 randomized trials.

Authors:  Andrew Moore; Geoffrey Makinson; Chunming Li
Journal:  Arthritis Res Ther       Date:  2013-01-08       Impact factor: 5.156

Review 3.  Tolerability and adverse events in clinical trials of celecoxib in osteoarthritis and rheumatoid arthritis: systematic review and meta-analysis of information from company clinical trial reports.

Authors:  R Andrew Moore; Sheena Derry; Geoffrey T Makinson; Henry J McQuay
Journal:  Arthritis Res Ther       Date:  2005-03-24       Impact factor: 5.156

4.  OptiBIRTH: a cluster randomised trial of a complex intervention to increase vaginal birth after caesarean section.

Authors:  Mike Clarke; Declan Devane; Mechthild M Gross; Sandra Morano; Ingela Lundgren; Marlene Sinclair; Koen Putman; Beverley Beech; Katri Vehviläinen-Julkunen; Marianne Nieuwenhuijze; Hugh Wiseman; Valerie Smith; Deirdre Daly; Gerard Savage; John Newell; Andrew Simpkin; Susanne Grylka-Baeschlin; Patricia Healy; Jane Nicoletti; Joan Lalor; Margaret Carroll; Evelien van Limbeek; Christina Nilsson; Janine Stockdale; Maaike Fobelets; Cecily Begley
Journal:  BMC Pregnancy Childbirth       Date:  2020-03-06       Impact factor: 3.007

5.  Dicing with chance, life and death in systematic reviews and meta-analyses: D.I.C.E. 3, a simulation study.

Authors:  Mike Clarke; Jim Halsey
Journal:  J R Soc Med       Date:  2014-02-13       Impact factor: 5.344

Review 6.  Physiotherapy versus placebo or no intervention in Parkinson's disease.

Authors:  Claire L Tomlinson; Smitaa Patel; Charmaine Meek; Clare P Herd; Carl E Clarke; Rebecca Stowe; Laila Shah; Catherine M Sackley; Katherine H O Deane; Keith Wheatley; Natalie Ives
Journal:  Cochrane Database Syst Rev       Date:  2013-09-10

7.  Cyclo-oxygenase-2 selective inhibitors and nonsteroidal anti-inflammatory drugs: balancing gastrointestinal and cardiovascular risk.

Authors:  R Andrew Moore; Sheena Derry; Henry J McQuay
Journal:  BMC Musculoskelet Disord       Date:  2007-08-03       Impact factor: 2.362

8.  How useful are systematic reviews for informing palliative care practice? Survey of 25 Cochrane systematic reviews.

Authors:  Bee Wee; Gina Hadley; Sheena Derry
Journal:  BMC Palliat Care       Date:  2008-08-20       Impact factor: 3.234

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.